Company / Shares Outstanding
AGIOS PHARMACEUTICALS, INC. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
57.2M
FY2025
5-year range
54.3M / 60.4M
FY2021-FY2025
Trend
+2.2%
vs FY2024
Sector context
#152 of 212
Health Care
What the data says
At 57156285.00, AGIOS PHARMACEUTICALS, INC.'s shares outstanding ranks #61 of 212 in the Health Care sector. Shares Outstanding has increased for 3 consecutive years, from 54334220.00 in FY2022 to 57156285.00 in FY2025.
Based on SEC 10-K filings.
57156285.00 in FY2025 with a 5-year CAGR of -3.5%.
Increased from 55039707.00 to 57156285.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Sector benchmark
#61 of 212 in Health CareTop 28% of 212This company 57.2M Sector average 306.0M
▼
-81.3% below sector average
Key checks
Key Insights
- AGIOS PHARMACEUTICALS, INC.'s shares outstanding has grown for 3 consecutive years.
- In FY2025, shares outstanding increased 2.2% year-over-year.
- Ranks #152 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 57.2M | +2.2% |
| FY2024 | 55.9M | +1.6% |
| FY2023 | 55.0M | +1.3% |
| FY2022 | 54.3M | -10.1% |
| FY2021 | 60.4M | -11.6% |
| FY2020 | 68.4M | +17.5% |
| FY2019 | 58.2M | +19.2% |
| FY2018 | 48.8M | +15.6% |
| FY2017 | 42.2M | +12.0% |
| FY2016 | 37.7M | +1.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026